Archive for April 2015
Acceptance with Resilience – Living with Chronic Pain
Several years ago, I happened to be reading a research article about people who had lost limbs in landmine explosions, when I ran across a psychological distinction that I’ve seen validated many times since then. It seems that one of the major factors determining the quality of recovery for someone who has suffered this kind…
Read MoreClinical Pain Advisor: Report on Opioids During Pregnancy Harms Pain Community
Editor’s Note: This post was originally published on Clinical Pain Advisor in response to an earlier story titled: Opioids During Pregnancy Affect Birth Weight, Respiratory Health. Vanderbilt University Medical Center reported a well-known link between opioid use during pregnancy and Neonatal Abstinence Syndrome (NAS) in a recently published study that is quickly gaining traction online. It is sparking a great deal of controversy — in part because there is…
Read MoreIneffective Treatment Associated with the Chronification of Pain
By Barby Ingle, President Power of Pain Foundation As a leader in the pain community and someone who personally advocates for pain patients on a daily basis, I strongly believe that we can combat the issues of abuse while still giving patients who need pain relief a safe, effective and accountable access to these medications.…
Read MoreJennifer Aniston’s Oscar-Worthy Performance Shows Life With Chronic Pain
Lynn R. Webster, MD Tinseltown does not generally have much in common with medicine, but the big screens will occasionally reflect what is happening in society. It’s been more than two decades since Tom Hanks won his first Best Actor Oscar award for his role in “Philadelphia,” a movie that contributed to a national social…
Read MoreDEA Inflicts Harm on Chronic Pain Patients
In an effort to curb opioid drug abuse and addiction, the Drug Enforcement Administration (DEA) has issued new rules that limit the accessibility of hydrocodone, putting chronic pain sufferers who rely on the drug in an impossible situation. The DEA’s new restrictions come after the decision to relabel hydrocodone as a Schedule II drug, making…
Read More